Mobile Menu
Deals & Transactions

Conyers advises Jazz Investments on further listing of Notes on Bermuda Stock Exchange

Conyers advised Jazz Investments I Limited, a Bermuda company and a wholly-owned subsidiary of Jazz Pharmaceuticals plc, on the listing on the Bermuda Stock Exchange of US$575,000,000 1.875% Exchangeable Senior Notes due 2021 (the “Notes”) issued by Jazz Investments I Limited, which listing became effective on October 12, 2017, immediately after the de-listing of the Notes from the Global Exchange Market of the Irish Stock Exchange.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs.

David J. Doyle, Kathleen Moniz and Kent Smith of Conyers’ Bermuda office worked on the matter working alongside A L Goodbody (London).

 


David J. Doyle
Director

BERMUDA   +1 441 299 4902


Kathleen Moniz
Associate

Bermuda   +1 441 298 7883


Kent Smith
Counsel

Bermuda   +1 441 299 4962


Accolades
_

"Few firms can come close to Conyers on one critical metric, and this is the breadth of the client base."
- IFLR1000

Related Jurisdictions

Bermuda


Related International Markets

Bermuda


Media Contact

For media enquiries, please contact media@conyersdill.com

Deals & Transactions

Conyers advises Jazz Investments on further listing of Notes on Bermuda Stock Exchange

Conyers advised Jazz Investments I Limited, a Bermuda company and a wholly-owned subsidiary of Jazz Pharmaceuticals plc, on the listing on the Bermuda Stock Exchange of US$575,000,000 1.875% Exchangeable Senior Notes due 2021 (the “Notes”) issued by Jazz Investments I Limited, which listing became effective on October 12, 2017, immediately after the de-listing of the Notes from the Global Exchange Market of the Irish Stock Exchange.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs.

David J. Doyle, Kathleen Moniz and Kent Smith of Conyers’ Bermuda office worked on the matter working alongside A L Goodbody (London).

 


David J. Doyle
Director

BERMUDA   +1 441 299 4902


Kathleen Moniz
Associate

Bermuda   +1 441 298 7883


Kent Smith
Counsel

Bermuda   +1 441 299 4962


 

JURISDICTION(S)

Bermuda


International Office(s)

Bermuda